XenoTherapeutics Foundation is a not-for-profit, clinical-stage regenerative medicine company developing new biotherapies from genetically engineered animals.

 

We understand the critical healthcare needs of a growing global population, and that is why we are dedicated to accelerating the testing, development, training, and commercialization of innovative, live biotherapeutic products to ensure that there will always be a sufficient supply to meet the true demand of the population.

 

In our research collaboration with Alexis Bio, we have developed our first product, realSKIN , which is pioneering the field of clinical xenotransplantation (transplantation of cells, tissues, and organs from one species to another).

 

Today the Xeno team has accomplished preclinical development in two IND-enabling studies for new biotherapies (skin and peripheral nerve transplants), progressed to Phase 3 clinical trials in a new field of medicine, and attained Orphan Drug and Regenerative Medicine Advanced Therapy Designations from the FDA for realSKIN .